nafronyl has been researched along with Kidney Diseases in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The mean values (+/-SD) of the pharmacokinetic parameters of naftidrofuryl for group A were as follows: tmax: 1." | 1.33 | Pharmacokinetics of naftidrofuryl in patients with renal impairment. ( Barbier, S; Bolloni, L; Bromet-Petitd, M; Chretien, P; Dupain, T; Fillastre, JP; Godin, M; Kuhn, T; Legallicier, B; Porte, F, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Legallicier, B | 1 |
| Barbier, S | 1 |
| Bolloni, L | 1 |
| Fillastre, JP | 1 |
| Godin, M | 1 |
| Kuhn, T | 1 |
| Porte, F | 1 |
| Chretien, P | 1 |
| Dupain, T | 1 |
| Bromet-Petitd, M | 1 |
1 other study available for nafronyl and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of naftidrofuryl in patients with renal impairment.
Topics: Adult; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Kidney Diseases; Kidney Fun | 2005 |